MedPath

A Study to Determine the Feasibility of Wireless Electrocardiography

Completed
Conditions
Atrial Fibrillation
Conduction Defects
Normal Sinus Rhythm
Premature Atrial and Ventricular Beats
Interventions
Device: Observational ambulatory ECG monitoring
Registration Number
NCT02162394
Lead Sponsor
Peerbridge Health, Inc
Brief Summary

The investigators are conducting a prospective, observational study to examine the ECG waveforms captured by the new medical device as compared to a traditional Holter monitor for subsequent use in visual diagnoses of atrial and ventricular arrhythmias as well as cardiac impulse and/or conduction disorders by qualified clinicians.

The hypothesis is that this new medical device prototype is non-inferior to traditional Holter monitoring for capturing ECG waveforms that can be visually assessed for atrial and ventricular arrhythmias as well as disorders of cardiac impulse formation and/or conduction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Patients must be at least 18 years of age
  • Patients must have a medical indication to wear a Holter monitor
  • Patients must not be pregnant
  • Patients must be able to comply with the study procedures
  • Patients must be willing to participate and able to provide informed consent
  • Patients must be willing to wear both devices (Holter and the wireless device prototype) simultaneously and continuously for a 2 to 3 hr period
Exclusion Criteria
  • Patients who are not able or willing to comply with study procedures
  • Patients with an existing implanted cardioverter-defibrillator and/or pacemaker
  • Patients with a known life threatening arrhythmia
  • Patients who manifest low voltage on their electrocardiogram
  • Patients affected by inflammatory and/or infectious skin disorders

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Referred for Holter monitoringObservational ambulatory ECG monitoring-
Primary Outcome Measures
NameTimeMethod
Percent of 8 second ECG strips of sufficient quality for visual diagnosis3 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Lenox Hill Hospital

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath